Abstract:Smoking is the leading cause of preventable cardiovascular disease (CVD). Epidemiologic and biologic evidence consistently demonstrates that smokers have an increased risk of CVD compared to nonsmokers. Both cardiac and extracardiac CVDs are more prevalent among smokers.Secondhand smoke is an important cause of CVD in nonsmokers. Secondhand smoke increases the risk of CVD by at least 30%, and given that a large part of the population is still breathing secondhand smoke, it is vital to counsel patients to avoid secondhand smoke exposure.The effects of tobacco smoke on the cardiovascular system accrue over a short period of time and are synergistic with other established cardiovascular risk factors. Tobacco smoke affects the cardiovascular system within minutes of exposure. Smokers and nonsmokers should be aware of this fact. Smokers should be encouraged to quit, and nonsmokers should fight for smoke-free environments.Every smoker should be encouraged to quit and every patient should be informed about the harmful effects of secondhand smoke (SHS) exposure. Smoking cessation has been proven to decrease mortality, regardless of age at quitting or disease stage. Several pharmacologic agents are now available to help patients quit. Pharmacotherapy is more likely to be effective if complemented with behavioral counseling. Secondhand smoke counseling will increase the likelihood of quitting for a smoker and encourage nonsmokers to advocate for smoke-free environments. At the very least, physicians should refer smokers to a quit line. Options should be discussed with the patient and behavioral treatment should be encouraged as it increases the likelihood of success. Smoking cessation is also effective in reducing CVD mortality. The excess risk of myocardial infarction (MI) is reduced by 50% within 1 year of quitting.Physicians should become tobacco control activists. A comprehensive tobacco control program, that includes taxation, smoke-free environments, and exposing the tobacco industry, has been shown to be effective in decreasing smoking prevalence and cardiovascular disease mortality. Physicians should become actively involved in the fight against tobacco.The mechanisms by which tobacco smoke leads to CVD include platelet activation, endothelial dysfunction, inflammation, altered lipid levels and metabolism, and hemodynamic effects. These effects interact with each other and are synergistic with other established CVD risk factors (e.g., obesity, diabetes). Some of these effects occur soon after exposure has happened; as little as half an hour of SHS exposure leads to platelet and endothelial dysfunction.A comprehensive tobacco control program reduces CVD mortality. Smoke-free environments are among the most effective measures to reduce CVD mortality. In addition to protecting nonsmokers from secondhand smoke, these environments make it easier for smokers to cut down or quit. Physicians should become active tobacco control advocates.

Advancements in Cardiovascular Disease Research Affected by Smoking

Genetic Influence on Cigarette-Induced Cardiovascular Disease

Epigenetics in Smoking-Associated Cardiovascular Diseases

Cigarette smoking and air pollution exposure and their effects on cardiovascular diseases

Effects of Smoking on the Pathogenesis of Chronic Obstructive Pulmonary Disease

Smoking, Secondhand Smoke, and Cardiovascular Disease

Smoking: a leading factor for the death of chronic respiratory diseases derived from Global Burden of Disease Study 2019

Effects of tobacco cigarettes, e-cigarettes, and waterpipe smoking on endothelial function and clinical outcomes

The Role of Smoking in the Mechanisms of Development of Chronic Obstructive Pulmonary Disease and Atherosclerosis

Effect of tobacco on periodontal disease and oral cancer

Altered Human Brain Anatomy in Chronic Smokers: a Review of Magnetic Resonance Imaging Studies

Health Effects of Tobacco at the Global, Regional, and National Levels: Results from the 2019 Global Burden of Disease Study

Relationship Between Increase of Serum Homocysteine Caused by Smoking and Oxidative Damage in Elderly Patients with Cardiovascular Disease.

Oxidative stress and inflammation: elucidating mechanisms of smoking-attributable pathology for therapeutic targeting

Smoking and the Pathophysiology of Peripheral Artery Disease

[Sex-Specific Associations Between Tobacco Smoking and Risk of Cardiovascular Diseases in Chinese Adults].

The Life-Course Impact of Smoking on Hypertension, Myocardial Infarction and Respiratory Diseases

Smoking and Atherosclerosis: Mechanisms of Disease and New Therapeutic Approaches

When smoke meets gut: deciphering the interactions between tobacco smoking and gut microbiota in disease development

Smoking, Blood Pressure, and Cardiovascular Disease Mortality in a Large Cohort of Chinese Men with 15 Years Follow-up.

Impact of smoking on pharmacotherapy of chronic obstructive pulmonary disease